Publications

Title

Info

To protect peptide pharmaceuticals against peptidases.

Rink, R., Arkema-Meter, A., Baudoin, I., Post, E., Kuipers, A., Nelemans, S.A., Haas-Jimoh-Akanbi, M., Moll, G.N. Pharmacol. Toxicol. Methods. 61, 210–218

Angiotensin-(1-7) with thioether-bridge: an ACE-resistant, potent Ang-(1-7) analogue

Kluskens, L.D., Nelemans, S.A., Rink, R., de Vries, L., Meter-Arkema, A., Wang, Y., Walther, T., Kuipers, A., Moll, G. N., and Haas, M. J. Pharmacol. Exper. Ther. 328, 849-854
A biological stabilization technology for peptide drugs: enzymatic introduction of thioether-bridges.

Moll, G.N. Kuipers, A., de Vries, L., Bosma, T., Rink, R. Drug Discov Today: Technol. doi:10.1016/j.ddtec.2009.03.
Translocation of a thioether-bridged azurin peptide fragment via the sec pathway in Lactococcus lactis

Kuipers, A., Rink, R., Moll, G.N. Appl. Environ. Microbiol. 75, 3800-3802
Mechanistic dissection of the enzyme complexes involved in the biosynthesis of nisin and lacticin 3147.

Kuipers, A., Meijer-Wierenga, J., Rink, R., Kluskens, L.D., and Moll, G.N. (2008), Appl. Environ. Microbiol. 74, 6591-6597

You are here